The current study tested the expectation that the effects of GLP-1 on brain glucose content, blood-brain glucose metabolism, and blood-brain glucose transfer, are additive in hypoglycemia because of the possibly enhanced CMRglc and Jglc noted in hyperglycemia, but the results were not consistent with this prediction. The gene discussed is GLP1R; the disease is Hypoglycemia.